Detalhe da pesquisa
1.
ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201.
JID Innov
; 4(2): 100251, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299059
2.
Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
J Pharmacol Exp Ther
; 317(3): 1044-53, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16501068